Search
SAB Biotherapeutics Inc
SABSAdd to Watchlist
3.570USD
+0.010+0.28%
Close 07-31 16:00（ET）Quotes delayed by 15 min
272.98MMarket Cap
8.35P/E TTM
SABS Financials
See SAB Biotherapeutics Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.
SAB Biotherapeutics Inc Earnings Date
Latest Release
Aug 6, 2026
EPS / Forecast
--/-0.29
Revenue / Forecast
--/0.00
Period
FY2025 Earnings
Revenue(YoY)
--
-100.00%
EPS(YoY)
0.22
105.99%
Analyst Rating
BUY
2026/08/02
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FAQs
What are the current assets of SAB Biotherapeutics Inc?
According to SAB Biotherapeutics Inc's FY2025 earnings report, its current assets were 101.05M, with a year-on-year change of 324.73.
What are the total assets of SAB Biotherapeutics Inc?
According to SAB Biotherapeutics Inc's FY2025 earnings report, its total assets of SAB Biotherapeutics Inc were 172.81M, with a year-on-year change of 291.01.
What are the total liabilities of SAB Biotherapeutics Inc?
According to SAB Biotherapeutics Inc's FY2025 earnings report, its total liabilities of SAB Biotherapeutics Inc were 21.32M, with a year-on-year change of 16.95.
What is the total equity of SAB Biotherapeutics Inc?
According to SAB Biotherapeutics Inc's FY2025 earnings report, its total equity of SAB Biotherapeutics Inc was 151.49M, with a year-on-year change of 483.35.
What is the net operating income of SAB Biotherapeutics Inc?
According to SAB Biotherapeutics Inc's FY2025 earnings report, its net operating income of SAB Biotherapeutics Inc was -48.85M, with a year-on-year change of -14.12.
What is the net investment of SAB Biotherapeutics Inc?
According to SAB Biotherapeutics Inc's FY2025 earnings report, its net investment of SAB Biotherapeutics Inc was -121.71M, with a year-on-year change of -917.42.
What is the net financing of SAB Biotherapeutics Inc?
According to SAB Biotherapeutics Inc's FY2025 earnings report, its net financing of SAB Biotherapeutics Inc was 168.30M, with a year-on-year change of 14452.36.
What is the Earnings Per Share (EPS) of SAB Biotherapeutics Inc?
According to SAB Biotherapeutics Inc's FY2025 earnings report, its Earnings Per Share (EPS) was 0.22, with a year-on-year change of 105.99.
What is the net income of SAB Biotherapeutics Inc?
According to SAB Biotherapeutics Inc's FY2025 earnings report, its net income was 4.26M, with a year-on-year change of 112.49.
What is the debt-to-asset ratio of SAB Biotherapeutics Inc?
According to SAB Biotherapeutics Inc's FY2025 earnings report, its debt-to-asset ratio was 1.90, with a year-on-year change of -77.32.
What is the Return on Equity (ROE) of SAB Biotherapeutics Inc?
According to SAB Biotherapeutics Inc's FY2025 earnings report, its Return on Equity (ROE) was 4.80, with a year-on-year change of 105.86.
What is the Return on Assets (ROA) of SAB Biotherapeutics Inc?
According to SAB Biotherapeutics Inc's FY2025 earnings report, its Return on Assets (ROA) was 12.23, with a year-on-year change of 122.98.
What is the operating profit of SAB Biotherapeutics Inc?
According to SAB Biotherapeutics Inc's FY2025 earnings report, its operating profit was -48.85M, with a year-on-year change of -14.12.